Treating a lupus flare depends on its severity, but the core approach combines short-term inflammation control (usually with steroids) alongside adjustments to your ongoing medications. Mild flares involving joint pain, rashes, or fatigue can often be managed at home with your rheumatologist’s guidance, while severe flares affecting the kidneys, brain, or blood cells may require hospitalization and aggressive treatment.
How Flare Severity Shapes Treatment
Lupus flares range from mild episodes you can manage in a clinic visit to life-threatening organ involvement. Doctors categorize them based on which organ systems are affected and how sharply your disease activity scores have risen. A mild or moderate flare typically means new or worsening joint pain, skin rashes, mouth ulcers, chest pain from pleurisy or pericarditis, or fevers. A severe flare involves the kidneys, central nervous system, blood vessels, or a dangerous drop in blood cell counts.
This distinction matters because it determines everything about your treatment plan: which medications, what doses, and whether you need to be treated in a hospital or at home.
Steroids for Rapid Inflammation Control
Steroids remain the fastest way to shut down a flare. They work within hours to days, which is why doctors have relied on them for decades. The goal with modern lupus care, though, is to use them as a short bridge while longer-acting medications take effect, then taper off as quickly as possible.
For a moderate flare, the typical approach is an intravenous pulse of methylprednisolone at 125 to 250 mg per day for three days, followed by oral prednisone starting at 5 to 20 mg daily. That oral dose is gradually reduced over two to four weeks down to 2.5 to 5 mg per day. For severe flares, the pulse dose increases to 250 to 500 mg per day for three days, with oral prednisone starting at up to 30 mg daily, then stepping down every two weeks until reaching 5 mg. In either case, the pulse can be repeated after two to four weeks if needed.
Methylprednisolone pulses at doses of 500 mg or less for three days appear to carry very few serious side effects, including minimal infection risk. The real damage from steroids comes with prolonged use at higher doses, which is why current guidelines emphasize keeping your maintenance dose at or below 5 mg of prednisone daily, and ideally stopping entirely when possible.
The Role of Hydroxychloroquine
If you’re not already taking hydroxychloroquine, a flare is a strong signal to start. The 2023 EULAR guidelines recommend it for all lupus patients without a specific contraindication, at a target dose based on your body weight. It serves as the foundation of lupus treatment year-round.
Hydroxychloroquine doesn’t work fast enough to calm an active flare on its own, but it reduces the frequency and severity of future flares. Patients who maintain blood levels in the effective range have 71% lower odds of active lupus and 26% lower odds of experiencing a flare over a nine-month period. It also reduces the risk of kidney flares, kidney failure, and death in people with lupus nephritis. One important note: smoking interferes with how well this medication works, which is one more reason to quit if you haven’t.
Immunosuppressants for Ongoing Control
Steroids buy time, but immunosuppressants are what keep flares from coming back. Your rheumatologist will likely start or adjust one of these medications during a flare, depending on which organs are involved.
- Mycophenolate is effective for both inducing remission and long-term maintenance, particularly when the kidneys are involved.
- Azathioprine is mainly used as maintenance therapy for moderate to severe lupus once a flare has been brought under control.
- Methotrexate works well when the flare primarily affects joints and skin.
- Cyclophosphamide is reserved for life-threatening organ involvement, including severe kidney disease and neuropsychiatric lupus. It’s a powerful drug with more side effects, so it’s typically used only when the situation demands it.
The 2023 EULAR guidelines recommend starting these medications promptly during a flare, not waiting until steroids have fully tapered. The goal is to overlap treatments so you can get off steroids faster while maintaining disease control.
Biologic Therapies
Two biologic medications have changed the treatment landscape for lupus patients who don’t respond well enough to conventional immunosuppressants. Belimumab targets a protein that helps immune cells survive and has consistently shown reductions in disease activity, steroid use, and flare frequency in clinical trials. Anifrolumab blocks a different immune signaling pathway and is another option your doctor may consider.
These biologics are typically added on top of your existing treatment rather than replacing it. The 2023 EULAR guidelines recommend considering them early alongside immunosuppressants, especially when the goal is to get steroid doses down quickly.
When a Flare Hits Your Kidneys
Kidney involvement, known as lupus nephritis, requires more aggressive treatment because untreated kidney inflammation can lead to permanent damage or kidney failure. The standard approach combines steroids with either mycophenolate or low-dose intravenous cyclophosphamide as anchor drugs.
Newer evidence shows that adding a calcineurin inhibitor (such as tacrolimus) to this regimen can significantly improve complete remission rates. A “multitarget” combination of mycophenolate, tacrolimus, and steroids has shown remission rates roughly 2.4 times higher than cyclophosphamide and steroids alone. These combination approaches also tend to carry lower infection risks than high-dose cyclophosphamide. Belimumab and a newer calcineurin inhibitor called voclosporin can also be added for active lupus nephritis under current guidelines.
Managing Symptoms at Home During a Flare
While your medications work to calm the underlying immune activity, how you manage your daily life during a flare makes a real difference in recovery. Fatigue during a flare can be crushing. Some people with lupus need up to 12 hours of sleep per night during active disease. Don’t fight that. Keep your daily schedule as simple as possible, shorten your to-do list, and pace your activities throughout the day rather than pushing through.
Sun protection is critical even when you’re not flaring, but especially during one. Between 23% and 83% of lupus patients are sensitive to ultraviolet radiation, and photosensitive reactions can appear up to three weeks after exposure, showing up as fatigue, joint pain, and new skin lesions. Stay out of direct sun between 10 AM and 4 PM, use broad-spectrum SPF 50 or higher sunscreen, and wear long sleeves, pants, and a hat when you’re outside. Ask your doctor whether any of your current medications increase sun sensitivity.
Preventing the Next Flare
Every flare carries some risk of lasting organ damage, so prevention is just as important as treatment. Staying on hydroxychloroquine consistently is the single most protective step. UV exposure is one of the most well-documented triggers, but stress, infections, and stopping medications abruptly can also set off a flare.
The treatment target in modern lupus care is remission or the lowest possible disease activity, maintained on 5 mg or less of prednisone daily. If your current regimen isn’t achieving that, it’s worth discussing whether adding an immunosuppressant or biologic could close the gap. Flares that happen while you’re already on treatment are a signal that your regimen may need to be escalated, not just that you need another round of steroids.